DUBLIN--(BUSINESS WIRE)--The "OTC Drugs, Medical Devices and Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering.
This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for OTC drugs, medical devices and diagnostic kits used for self-care and the management of various common diseases.
The report considers only Western or modern drugs and excludes any other type of drugs such as alternative therapies. This report covers medical devices and diagnostic kits exempted by the U.S. FDA for OTC use.
This study aims to provide an understanding of the dynamics and forecasts of the OTC drugs, medical devices and diagnostic kits market worldwide and provides key market propositions over a five-year forecast period.
The report covers developed and emerging markets in order to help readers understand:
- Detailed description, including demographics and cost burden, of various diseases including cardiovascular diseases, orthopedic diseases, respiratory disorders, diabetes, obesity, gastrointestinal disorders, sleep disorders, skin disorders, and ENT disorders.
- Detailed description and analysis of current OTC drugs, medical devices and diagnostic kits.
- Market characterization, unmet need, and market size and segmentation (by region, by segment, by diseases).
- The current state of the market and the key markets for its future development.
- Major regional trends.
- Market drivers and restraints.
- Detailed market projections through 2024.
- Global competitive thrust in terms of competition and market shares.
- Key marketed and pipeline (research and development) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Regulatory structure: new regulations that will influence the development of the OTC drugs, devices and diagnostics market.
- Pricing and reimbursement.
- Observations and conclusions on the future of OTC drugs, medical devices and diagnostics.
- Profiles of market participants and associations.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Target Diseases and Disorders
- Overview of Common Diseases and Disorders for OTC
- Cardiovascular Disease
- Lifestyle Disorders
- Respiratory Disorders
- Musculoskeletal Disorders
- Mental/Mood Disorders
- Gastrointestinal Disorders
- Urology Disorders
- Chronic Wounds
- Chronic Pain
- Panic Disorder/Anxiety Disorder
- ENT Disorders
- Dental Disorders
- Eating Disorders
- Tobacco Smoking and Associated Diseases
- Chronic Diseases: Expanding Horizon for OTC Market
- Aging, Gender and Onset of Diseases
- Global Demographics
- U.S. Demographics
- U.S.: Gender, Age and Life Expectancy
- European Demographics
- Japanese Demographics
- Current Challenges and Future Directions
Chapter 4 OTC Drugs and Nutritional Supplements
Chapter 5 OTC Medical Devices and Diagnostics
- Medical Devices, Diagnostics and Disease Management
- Clinical and Market Need of OTC Devices and Diagnostics
- Types of OTC Devices and Diagnostics
- Self-Care Devices and Wearables
- Diagnostic Devices and Kits
- Key Products
- Diagnostic and Monitoring Devices
- Therapeutic Devices and Technologies
- Remote Patient Monitoring and Home Healthcare
- Advantages of Disease Management via Digital Care
- Unmet Need
- Current Challenges
- Future Outlook
Chapter 6 OTC Devices for Treatment Adherence
- Treatment Nonadherence
- Market Need for OTC Medication Adherence Devices
- Hardware-Centric OTC Medication Adherence Devices
- Smart Pill Bottle
- Automated Pill Dispenser
- Electronic Tray
- Smart Caps
- Other Adherence Devices and Solutions
- Key Products
- Smart Pill Dispensers, Pillboxes, Organizers, Smart Pill Cap and Bottle Systems
- Other OTC Adherence Devices
- Current Challenges
- Future Developments
Chapter 7 Market Size and Growth Analysis
Chapter 8 Competitive Landscape in the OTC Drugs, Medical Devices and Diagnostics Market
- Competitive Landscape: Disease Treatment and Management with OTC Drugs, Medical Devices and Diagnostic Technologies
Chapter 9 Strategies in the OTC Drugs, Medical Devices and Diagnostics Market
- Consolidation in the OTC Drugs and Devices Market
- Mergers and Acquisitions in the OTC Drugs, Medical Devices and Diagnostics Market
- OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
- OTC Medical Devices and Diagnostics
- Recent Mergers and Acquisitions
- OTC Medical Devices and Diagnostics
- OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
- Minority Stakes and Future Options to Acquire
- Future Strategic Landscape
Chapter 10 Regulatory Structure: Pharmaceuticals, Medical Devices and Diagnostics
- Regulatory Background
- Regulatory Systems for Medical Devices, by Region
- U.S.
- European Union
- Japan
- Regulatory Systems for Pharmaceuticals, by Region
- U.S.
- Europe
- Japan
- Rules and Regulations for OTC Drugs and Dietary Supplements
- Regulations for OTC drugs
- Regulations for Dietary Supplements
Chapter 11 Pricing and Reimbursement: Pharmaceuticals, Medical Devices and Diagnostics
- Pricing and Reimbursement Background
- Pricing and Reimbursement for Medical Devices, by Region
- U.S.
- Europe
- Japan
- Other Asia-Pacific
- Pricing and Reimbursement for Pharmaceuticals, by Region
- U.S.
- Europe
- Japan
Chapter 12 Conclusions-Outlook for OTC Drugs, Medical Devices and Diagnostics
- Major Developments Influencing the Market
- Technological Developments
- Demographic and Economic Trends
- Changing Structure of the Healthcare Industry
- Lifestyle Medicine
- Patient-Centric Programs
- Prevalence of Self-Care
- Burden on Public Health System
- Retain Market Leadership
- Long-Term Outlook
Chapter 13 Company Profiles
Chapter 14 Appendix A: List of Acronyms
Chapter 15 Appendix B: Professional Organizations
Companies Mentioned
- 3M
- Abbott Laboratories
- Abbvie Inc.
- Acadia Pharmaceutical
- Acorda Therapeutics
- Actavis plc
- Actualmeds
- Adherium
- Aethlon Medical Inc.
- Agenus
- Akron
- Alacer Corp.
- Alcon Inc.
- Alere Inc.
- Alfresa Pharma Corp.
- Aliphcom Inc.
- Alivecor
- Alkalon A/S
- Alkermes
- Allergan
- Alliance Healthcare
- Amgen Inc.
- Amiko
- Amneal Pharmaceuticals
- Anavex Life Sciences
- Ani Pharmaceuticals
- Animas (A Subsidiary of Johnson & Johnson)
- Apotex
- Archos
- Arena Pharmaceuticals
- Array Biopharma
- Asahi Kasai Corp.
- Aslan Pharmaceuticals
- Aspen Pharmacare
- Astellas Pharma Inc.
- Astrazaneca plc
- Athersys
- Audentes Therapeutics
- Axiobionics
- Axsome Therapeutics
- Bausch & Lomb
- Bausch Health
- Baxter International Inc.
- Bayer AG
- Beigene
- Bespak Europe
- Biomerieux
- Biosensics
- Bioserenity
-
And Many More Companies!
For more information about this report visit https://www.researchandmarkets.com/r/9n93up
